Osteoarthritis Market Report 2026

Osteoarthritis Market Overview

• Osteoarthritis market size has reached to $7.49 billion in 2025 • Expected to grow to $11.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Rising Obesity-Related Disorders Fuel Growth In The Osteoarthritis Market • Market Trend: Partnership Approaches And Advanced Treatments Transform The Osteoarthritis Market • North America was the largest region in 2025.

What Is Covered Under Osteoarthritis Market?

Osteoarthritis is a form of arthritis that solely affects the joints, typically the hands, knees, hips, neck and lower back. It develops when the cartilage that covers and shields the ends of the bones gradually erodes. Osteoarthritis treatment aims to reduce pain, improve joint function and slow down the progression of the disease. The main treatments for osteoarthritis are medication, surgery and therapy. Medication refers to the use of medications or medicine to treat or relieve a certain condition or illness. Osteoarthritis pain can be reduced with the use of medications including nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen and opioids. The diagnosis includes imaging and joint fluid analysis. The medication can be administered through the parenteral route, topical route and oral routes for the treatment of knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis and hand osteoarthritis. The end-users are hospitals and medical institutes.

What Is The Osteoarthritis Market Growth Forecast?

The osteoarthritis market size is expected to see strong growth in the next few years. It will grow to $11.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to rising adoption of minimally invasive and robotic-assisted surgeries, increasing use of biologics and dmoads, expanding healthcare infrastructure for joint care, growing adoption of digital diagnostics and ai-based monitoring, increasing patient awareness of lifestyle and weight management programs. Major trends in the forecast period include rising adoption of minimally invasive joint replacement surgeries, increasing use of biologic therapies and hyaluronic acid injections, growing integration of digital imaging and ai-based diagnostics, rising focus on personalized osteoarthritis management plans, increasing investment in physical therapy and rehabilitation programs.

Global Osteoarthritis Market Segmentation

1) By Treatment: Medication, Surgery, Therapy 2) By Diagnosis: Imaging, Joint Fluid Analysis 3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route 4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis 5) By End-User: Hospitals, Medical Institutes Subsegments: 1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs) 2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion 3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

What Is The Driver Of The Osteoarthritis Market?

The increasing obesity-related disorders are expected to boost the growth of the osteoarthritis market going forward. Obesity-related problems refer to a range of health issues that can arise from excessive body fat. It is caused by consuming more calories than the body burns through physical activity and exercise, eating large amounts of processed or fast food, and drinking too much alcohol. Obesity can induce osteoarthritis by putting strain on joints, producing inflammation, and altering hormones, thus increasing the load on the joints. For instance, in September 2024, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, the number of states with adult obesity prevalence of 35% or higher rose from 22 states in 2022 to 23 states in 2023. Therefore, the increasing obesity-related disorders are driving the growth of the osteoarthritis industry.

Key Players In The Global Osteoarthritis Market

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Global Osteoarthritis Market Trends and Insights

Major companies operating in the osteoarthritis market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in July 2024, LG Chem, a South Korea-based pharmaceutical company, entered the Chinese market through a partnership with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and production company, to launch Synovian injection for osteoarthritis and provide similar therapeutic effects to traditional multi-injection formulations but with just one administration. Unique features of Synovian include its high molecular weight (10 million Dalton) hyaluronic acid, which enhances viscoelasticity and joint function, and its ability to significantly reduce knee pain based on clinical phase 3 trial results. This advancement positions Synovian as an effective option for patients seeking convenient relief from osteoarthritis symptoms.

What Are Latest Mergers And Acquisitions In The Osteoarthritis Market?

In November 2023, Smith & Nephew, a UK-based medical-technology company specializing in orthopaedics, sports medicine, arthroscopic technologies, and wound care, acquired CartiHeal for US$180 million upfront. With this acquisition, Smith & Nephew aims to expand its osteoarthritis and joint-repair portfolio through the integration of a biologic cartilage-regeneration technology, strengthening its long-term leadership in sports medicine. CartiHeal is an Israel-based developer of the Agili-C scaffold, a porous, biocompatible implant designed for one-step cartilage and subchondral bone repair in knees with osteochondral lesions, including those in mild to moderate osteoarthritis.

Regional Outlook

North America was the largest region in the osteoarthritis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Osteoarthritis Market?

The osteoarthritis market consists of revenues earned by entities by providing services such as physical therapy, occupational therapy, weight management, exercise and physical activity, patient education, self-management programs and joint protection techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis market also includes sales of viscosupplementation agents, analgesics, corticosteroids and assistive devices such as braces, canes, or shoe inserts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Osteoarthritis Market Report 2026?

The osteoarthritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the osteoarthritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.